Search for large extra dimensions via single photon plus missing energy final states at root s=1.96 TeV

We report on a search for large extra dimensions in a data sample of approximately 1 fb(-1) of p (p) over bar collisions at root s=1.96 TeV. We investigate Kaluza-Klein graviton production with a photon and missing transverse energy in the final state. At the 95% C.L. we set limits on the fundamental mass scale M(D) from 884 to 778 GeV for two to eight extra dimensions.

Upper bounds on the photon mass

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Search for Dark Matter and Large Extra Dimensions in pp Collisions Yielding a Photon and Missing Transverse Energy

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Measurement of the differential cross section for isolated prompt photon production in pp collisions at 7 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Search for supersymmetry in events with a lepton, a photon, and large missing transverse energy in pp collisions at root s=7 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Efficiency of ethanol conversion induced by controlled modification of pore structure and acidic properties of alumina catalysts

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Site-selective ethanol conversion over supported copper catalysts

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Up-conversion properties of lanthanide-organic frameworks and how to track ammunitions using these materials

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

1.5 mu m and visible up-conversion emissions in Er3+/Yb3+ co-doped tellurite glasses and optical fibers for photonic applications

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Development of rapidly fermenting strains of saccharomyces-diastaticus for direct conversion of starch and dextrins to ethanol

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

IDENTIFYING THE HIGGS-BOSON IN ELECTRON-PHOTON COLLISIONS

We analyze the production and detection of the Higgs boson in the next generation of linear e+e-colliders operating in the egamma mode. In particular, we study the production mechanism e+gamma --> egammagamma --> e + H, where one photon is generated via the laser backscattering mechanism, while the other is radiated via the usual bremsstrahlung process. We show that this is the most important mechanism for Higgs boson production in a 500 GeV egamma collider for M(H) greater than or similar to 140 GeV. We also study the signals and backgrounds for detection of the Higgs boson in the different decay channels bbBAR, W+W-, and ZZ, and suggest kinematical cuts to improve the signature of an intermediate-mass Higgs boson.

PRODUCTION OF Z-HIGGS BOSON PAIRS AT PHOTON LINEAR COLLIDERS

We study the associated production of Z and standard model Higgs bosons in high energy gamma gamma collisions with the photons originating from Compton laser backscattering. According to our results, within the framework of the standard model, this process will give rise only to very few events for a yearly integrated luminosity of 10 fb(-1), even at very high energies.

Antimony orthophosphate glasses with large nonlinear refractive indices, low two-photon absorption coefficients, and ultrafast response

Antimony glasses based on the composition Sb2O3-SbPO4 were prepared and characterized. The samples present high refractive index, good transmission from 380 to 2000 nm, and high thermal stability. The nonlinear refractive index, n(2), of the samples was studied using the optical Kerr shutter technique at 800 nm. The third-order correlation signals between pump and probe pulses indicate ultrafast response (<100 fs) for all compositions. Enhancement of n(2) was observed by adding lead oxide to the Sb2O3-SbPO4 composition. Large values of n(2)approximate to10(-14) cm(2)/W and negligible two-photon absorption coefficients (smaller than 0.01 cm/GW) were determined for all samples. The glass compositions studied present appropriate figure-of-merit for all-optical switching applications. (C) 2005 American Institute of Physics.

DECIPHERING THE QUARK-GLUON STRUCTURE OF THE PHOTON IN E-GAMMA COLLISIONS

We investigate the capability of an egamma collider to unravel the hadronic content of the photon. The experimental problem for probing the gluonic structure of the photon is that small-x triggers overwhelmingly select soft photons rather than soft gluons in hard photons. We show that the problem can be finessed in experiments where laser back-scattering is used to prepare a source of very hard photons. We illustrate their power for studying the parton distributions of the photon and, specifically, for separating the quark and gluon components in events where dijets, jet-gamma pairs, and heavy quark pairs are produced.

Conversion of immunosuppressive monotherapy from cyclosporin A to tacrolimus reverses bone loss in rats

Tacrolimus is used for transplant patients with refractory graft rejection and those with intolerance to cyclosporin (CsA), without the disfiguring adverse effects frequently attributed to CsA therapy. Since we have shown that CsA-associated bone loss can also affect alveolar bone, the purpose of this study was to evaluate the effects of conversion of monotherapy from CsA to tacrolimus on alveolar bone loss in rats. Groups of rats were treated with either CsA (10 mg/kg/day, s.c.), tacrolimus (I mg/kg/day, s.c.), or drug vehicle for 60 and 120 days, and an additional group received CsA for 60 days followed by conversion to tacrolimus for a further 60-day period. Bone-specific alkaline phosphatase (BALP), tartrate-resistent acid phosphatase (TRAP-5b), calcium (Ca2+), interleukin (IL)-1 beta, IL-6, and tumor necrosis factor alpha (TNF-alpha) concentrations were evaluated in the serum. Analyses of bone volume, bone surface, number of osteblasts, and osteoclasts were performed. Treatment with CsA for either 60 or 120 days was associated with bone resorption, represented by lower bone volume and increased number of osteoclasts; serum BALP, TRAP-5b, IL-1 beta, IL-6, and TNF-alpha were also higher in these animals. After conversion from CsA to tacrolimus, all the altered serum markers returned to control values in addition to a significant increase of bone volume and a lower number of osteoclasts. This study shows that conversion from CsA to tacrolimus therapy leads to a reversal of the CsA-induced bone loss, which can probably be mediated by downregulation of IL-1 beta, IL-6, and TNF-alpha production.